Financial performance
Search documents
Lindsay Corporation (NYSE:LNN) Surpasses EPS Estimates but Misses on Revenue
Financial Modeling Prep· 2026-01-09 17:00
Core Insights - Lindsay Corporation reported earnings per share (EPS) of $1.54, exceeding the estimated $1.46, while revenue was approximately $155.8 million, slightly below the estimated $163 million [1][6] Financial Performance - During Q1 2026 earnings call, the company noted a decline in revenues in both North American and international markets, but improved its irrigation operating margin, indicating efficient cost management [2] - The infrastructure segment experienced a 17% increase in revenues, driven by higher sales of road safety products, showcasing the company's ability to meet market demand [3] Strategic Initiatives - Lindsay Corporation secured an $80 million irrigation contract, which further strengthens its financial performance and market position [3] Valuation Metrics - The company has a price-to-earnings (P/E) ratio of approximately 18.41, a price-to-sales ratio of about 2.06, and an enterprise value to sales ratio of around 1.95, reflecting favorable market valuation [4] Financial Health - Lindsay Corporation maintains a strong liquidity position with a current ratio of 3.42, indicating its ability to cover short-term liabilities with short-term assets [5] - The debt-to-equity ratio stands at 0.25, suggesting a relatively low level of debt compared to equity, indicating financial stability [5] - The company's earnings yield is 5.43%, providing insight into the return on investment for shareholders [5]
CorMedix Therapeutics Price Target and Financial Performance Overview
Financial Modeling Prep· 2026-01-09 01:00
Truist Financial sets a new price target of $16 for CorMedix Therapeutics (NASDAQ:CRMD), indicating an 84.95% potential upside.CorMedix reports preliminary unaudited net revenue of $127 million for Q4 and $400 million for the full year of 2025.The company's adjusted EBITDA for Q4 is expected to be between $77 million and $81 million, showcasing strong operational performance.CorMedix Therapeutics, trading on the NASDAQ under the symbol CRMD, is a biopharmaceutical company focused on developing and commercia ...
LHV Group results in November 2025
Globenewswire· 2025-12-16 06:00
Core Insights - LHV Group reported increased profits and business volumes in November, with a consolidated net profit of EUR 11.9 million and a return on equity of 19.3% [2][7] - The loan portfolio grew by EUR 94 million to EUR 5.38 billion, while deposits rose by EUR 155 million to EUR 7.66 billion [1][7] - The number of customers at LHV Pank increased by 2,875, reaching a total of 489,000 [3][8] Financial Performance - Consolidated net profit for November was EUR 11.9 million, with contributions from subsidiaries: AS LHV Pank (EUR 11.4 million), LHV Bank Ltd (EUR 0.9 million), AS LHV Varahaldus (EUR 0.2 million), and AS LHV Kindlustus (EUR 0.04 million) [2] - The loan portfolio of LHV Pank reached EUR 4.65 billion, with a monthly increase of EUR 40 million [3] - LHV Bank in the UK saw loan volumes increase by EUR 55 million, bringing the total loan portfolio to EUR 728 million [4] Customer and Deposit Growth - The total number of customers for LHV Pank reached 489,000, with a deposit volume of EUR 6.64 billion [3][8] - LHV Bank's total deposits increased by EUR 119 million to EUR 1.20 billion [4] Fund Performance - LHV Varahaldus funds showed modest performance with increases of 0.6% and 0.3% for the largest funds, while the pension fund Indeks rose by 0.9% [5] Insurance Operations - LHV Kindlustus signed new insurance contracts worth EUR 3.3 million, with approximately 298,000 contracts in force by the end of November [6] - The net expense ratio for LHV Kindlustus was 30.7%, influenced by a sales campaign that boosted growth in motor insurance [6] Year-to-Date Performance - LHV Group's net income for the year is EUR 8.7 million below the financial plan, while the loan portfolio and deposits exceed the plan by EUR 114 million and EUR 168 million, respectively [7]
Akamai Technologies Inc. (NASDAQ: AKAM) Financial Overview
Financial Modeling Prep· 2025-12-16 03:00
Core Viewpoint - Akamai Technologies Inc. demonstrates strong financial performance and market position, significantly outperforming competitors like Sprout Social in various financial metrics [1][2][6]. Financial Performance - Akamai has a net margin of 12.26%, return on equity of 14.16%, and return on assets of 6.33%, indicating robust profitability [2]. - The company reported gross revenue of $3.99 billion and a net income of $504.92 million, with earnings per share at $3.41 and a price/earnings ratio of 25.18 [3][6]. Valuation Metrics - Akamai's price-to-earnings ratio is approximately 24.89, reflecting investor confidence in its earnings potential [4]. - The price-to-sales ratio is about 3.01, and the enterprise value to sales ratio is around 4.05, indicating a strong market valuation [4]. Financial Stability - The company has a debt-to-equity ratio of about 1.11 and a current ratio of approximately 2.28, suggesting effective management of financial obligations and short-term liabilities [5][6].
PhenixFIN Corporation's Financial Performance Highlights
Financial Modeling Prep· 2025-12-13 10:00
PhenixFIN Corporation (NASDAQ:PFX) reported an EPS of $0.433, slightly above the estimated $0.43, showcasing its ability to surpass expectations.The company's revenue for the fourth quarter of 2025 was $6.9 million, exceeding the estimated $5.81 million and continuing its trend of outperforming revenue expectations.PhenixFIN's net asset value (NAV) stood at $160.8 million as of September 30, 2025, with a weighted average yield on debt and other income-producing investments of 12.8%.PhenixFIN Corporation, tr ...
Quanex Building Products Corporation's Impressive Financial Performance
Financial Modeling Prep· 2025-12-12 07:00
Core Insights - Quanex Building Products Corporation (NX) is a significant player in the building products industry, focusing on engineered products for the window and door sector, and has shown notable improvements in financial performance [1] Financial Performance - NX reported earnings per share (EPS) of $0.83, exceeding the estimated $0.50, resulting in a 66% earnings surprise, and showing growth from $0.61 in the same quarter last year [2] - Revenue reached approximately $489.8 million, surpassing the estimated $470.7 million by 3.78%, although slightly lower than the $492.16 million reported in the same period last year [3] Growth and Debt Management - The company achieved a net sales growth of approximately 44% year-over-year for the fiscal year ending October 31, 2025, and successfully repaid $75 million of debt, improving its balance sheet [4] - Cash provided by operating activities increased by about 86%, indicating strong liquidity [4] Financial Health Metrics - NX maintains a current ratio of approximately 2.04, reflecting a strong liquidity position, while its debt-to-equity ratio stands at about 1.18, indicating significant use of debt financing relative to equity [5] - The integration of the transformative acquisition of Tyman is substantially complete, aligning with NX's strategic objectives and positioning the company for future growth [5]
Lululemon Athletica Inc. (NASDAQ:LULU) Surpasses Earnings Estimates
Financial Modeling Prep· 2025-12-12 06:00
Core Insights - Lululemon Athletica Inc. is a leading player in the athletic apparel industry, known for its high-quality yoga and fitness wear, competing with brands like Nike and Under Armour [1] Financial Performance - The company reported earnings per share (EPS) of $2.59, exceeding the estimated $2.21, resulting in a significant earnings surprise of 16.67% [2][6] - Revenue for the third quarter ending October 2025 was $2.57 billion, reflecting a 7.1% increase from the same period last year and surpassing the Zacks Consensus Estimate of $2.48 billion by 3.4% [3][6] Market Valuation - Lululemon's price-to-earnings (P/E) ratio is approximately 12.74, and its price-to-sales ratio stands at about 1.92, indicating the market's valuation of the company's earnings and revenue [4] - The enterprise value to sales ratio is around 1.98, further illustrating how the market values the company relative to its sales [4] Financial Stability - The company maintains a debt-to-equity ratio of approximately 0.37, suggesting a relatively low level of debt compared to its equity [5][6] - A current ratio of about 1.51 indicates Lululemon's ability to cover short-term liabilities with short-term assets, reinforcing its financial stability [5][6]
American Outdoor Brands, Inc. (NASDAQ:AOUT) Financial Performance Overview
Financial Modeling Prep· 2025-12-10 08:00
Core Viewpoint - American Outdoor Brands, Inc. (AOUT) has demonstrated strong earnings performance despite challenges in revenue growth, indicating effective cost management and operational efficiency [1][2][3]. Financial Performance - AOUT reported an EPS of $0.29, significantly exceeding the consensus estimate of $0.17, resulting in an earnings surprise of over 70% [2][5]. - The company's revenue was approximately $57.2 million, which fell short of the estimated $59.8 million and decreased from $60.23 million reported in the same quarter of the previous year [3][5]. Valuation Metrics - The price-to-sales ratio is 0.47, indicating the stock is valued at less than half of its sales per share [4]. - The enterprise value to sales ratio is 0.62, reflecting the company's total valuation relative to its sales [4]. Liquidity and Debt - AOUT has a robust liquidity position with a current ratio of 4.40, suggesting it can cover its short-term liabilities [4][5]. - The debt-to-equity ratio is 0.19, indicating a relatively low level of debt compared to equity [4]. Cash Flow Challenges - The enterprise value to operating cash flow ratio is -94.93, highlighting significant challenges in generating positive cash flow from operations [4][5].